The study found that the five-year mortality rate was significantly lower among patients who were using GLP-1 receptor ...

While drugs like Wegovy, Ozempic and Mounjaro are hailed for regulating blood sugar and helping people lose weight, new ...

Lung cancer remains the leading cause of cancer death, but advances in screening, surgery and personalized treatment are ...

In a retrospective analysis, patients with colon cancer taking GLP-1 agonists had a 62% lower risk of 5-year mortality ...

For decades, immune-based cancer therapies have offered hope but also risk, with powerful tumor-fighting effects often ...

Scientists have known that obesity and metabolic dysfunction can make cancers more aggressive. Tumors thrive in bodies ...

GLP-1 drugs such as Ozempic and Wegovy may extend the lives of colon cancer patients, according to a major UC San Diego study ...

GLP-1 receptors - the drugs behind Ozempic and Mounjaro - could have great benefits for colon cancer patients, the study ...

Higher body mass index (BMI) after diagnosis is linked to better survival outcomes in patients with localized renal cell ...

A UC San Diego study reveals GLP-1 receptor agonists, like Ozempic, may significantly reduce colon cancer death rates.

Can psilocybin help people with advanced cancer who are coping with anxiety, depression, fear of death, and loss of hope?

For the first time in more than a decade, a new frontline treatment for an incurable blood cancer is being added to the ...